In March of 2021 Lilly Dermatology held a webinar for Australian dermatologists to discuss updates in the management of psoriasis and atopic dermatitis. Dermatologist and senior lecturer Dr Diana Rubel of Woden Dermatology in Phillip (ACT) presented 5-year safety data published in 2020 on ixekizumab. Dr Lynda Spelman, founder and director of the Queensland Institute ...
Experts weigh in on the targeted management of psoriasis and atopic dermatitis
20 Jul 2021
Sponsored by Eli Lilly Australia Pty Ltd